Home
NewsNewsIVI RMA North America has launched the IVI RMA Patient Advisory Council in the US and Canada to strengthen patient-centered care. The councils bring patients, clinicians, and leadership together in structured monthly discussions, ensuring real patient experiences inform fertility care improvements, service innovation, and long-term clinical strategies.
In a decisive stride toward deeper patient engagement, IVI RMA North America has introduced two new Patient Advisory Councils, one in the United States and one in Canada, designed to elevate firsthand experiences into strategic action. These councils are set up as collaborative forums where patients, their partners, and clinical teams come together in open dialogue to shape the future of care delivery with empathy and clarity.
Launching virtually on December 16, 2025, in the U.S. and January 14, 2026, in Canada, the IVI RMA Patient Advisory Council initiative will meet monthly, building ongoing channels for real-time feedback that influence care standards and organizational priorities. Featuring a blend of patient representatives from each market alongside practice leaders, medical directors, and executive teams, these councils aim to fuse real lived experiences with system-wide planning.
According to Iris González, Chief Operating Officer at IVI RMA North America, this approach will help the organization refine its patient-centered care by listening to what truly matters to the people they serve, driving improvements grounded in authenticity rather than assumption. Leadership across the network will harness insights from these advisory bodies to steer enhancements across patient services, engagement, and innovative care programs.
IVI RMA North America, home to iconic fertility brands including Reproductive Medicine Associates, Boston IVF, and TRIO has built its reputation on evidence-based treatments and cutting-edge research, contributing to more than 220,000 births to date. With these councils in motion, the network is poised to set a new benchmark for patient partnership in reproductive health care.
A new Ipsos survey commissioned by Fertility Matters Canada finds 49% of Canadians with an opinion support a national baseline for IVF funding support, with backing rising to 59% among those aged 18–34. One in eight Canadians say cost has already forced them or someone close to delay or abandon fertility treatment.
Alpha Controls & Instrumentation Inc. has been selected by FertiTech Canada Inc. as its third-party calibration partner for Nilotech temperature probes. The partnership channels Canadian IVF laboratories and fertility clinics using Nilotech equipment to Alpha Controls for professional, accredited calibration services, while FertiTech continues to handle equipment supply and gas sensor calibration.
In the UK, a Ten Minute Rule Bill has been introduced in the Commons to create a legal right to paid time off for fertility treatment, aiming to standardize access to time‑sensitive appointments and reduce reliance on employer discretion. The proposal seeks House permission to proceed and spotlights workplace rights during Fertility Awareness Week.
Columbia University Fertility Center has achieved the first confirmed pregnancy using an AI-guided sperm recovery method in a man with azoospermia, as detailed in The Lancet. The STAR system combined advanced imaging, microfluidics, and robotics to retrieve two viable sperm, enabling embryo creation after prior failed surgical and manual attempts.
British Columbia's free IVF program exhausts 2025 funding within months of launch. At least one approved clinic stops accepting new applications. Applicants face aging-out risks and must wait until spring 2026 for next funding allocation.
Singapore’s MOH approves 13 additional genetic conditions for testing before embryos are implanted during IVF, enhancing reproductive genetic screening options.
National Health Service-funded IVF in England varies across regions in terms of access, cycle definitions, and eligibility. While Integrated Care Boards follow NICE guidelines, local implementation differs to meet specific population needs. Current policy reviews aim to enhance consistency and ensure continued access to fertility services across England.
